Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease
Open Access
- 31 May 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1357
Abstract
The human gut microbiome is intricately linked to systemic and organ-specific immune responses and is highly responsive to dietary modulation. As metagenomic techniques enable in-depth study of an ever-growing number of gut microbial species, it has become increasingly feasible to decipher the specific functions of the gut microbiome and how they may be modulated by diet. Diet exerts both supportive and selective pressures on the gut microbiome by regulating a multitude of factors, including energy density, macronutrient and micronutrient content, and circadian rhythm. The microbiome, in turn, contributes to local and systemic immune responses by providing colonization resistance against pathogens, shaping immune cell activity and differentiation, and facilitating the production of bioactive metabolites. Emerging research has strengthened the connections between the gut microbiome and cardiometabolic disorders (e.g., cardiovascular disease, obesity, type-2 diabetes), autoimmune conditions (e.g., type-1 diabetes, rheumatoid arthritis, celiac disease), respiratory disease, chronic kidney and liver disease, inflammatory bowel disease, and neurological disorders (e.g., Alzheimer’s, Parkinson’s disease, depressive disorders). Here, we outline ways in which dietary factors impact host response in diseases through alterations of gut microbiome functionality and composition. Consideration of diet-mediated microbial effects within the context of the diseases discussed highlights the potential of microbiome-targeted treatment strategies as alternative or adjunct therapies to improve patient outcomes.Keywords
Funding Information
- Crohn’s and Colitis Foundation (CCF) and American Heart Association (AHA) Career Development Awards (#854385, #855256)
This publication has 420 references indexed in Scilit:
- Fecal Microbiota Transplantation for Treatment of Parkinson DiseaseJAMA Neurology, 2024
- MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectivesMolecular Oncology, 2024
- Butyrate Attenuates Hepatic Steatosis Induced by a High‐Fat and Fiber‐Deficient Diet via the Hepatic GPR41/43‐CaMKII/HDAC1‐CREB PathwayMolecular Nutrition & Food Research, 2022
- The role of gut microbiota in infectious diseasesWIREs Mechanisms of Disease, 2022
- Trends in Consumption of Ultraprocessed Foods Among US Youths Aged 2-19 Years, 1999-2018JAMA, 2021
- Foodborne Titanium Dioxide Nanoparticles Induce Stronger Adverse Effects in Obese Mice than Non‐Obese Mice: Gut Microbiota Dysbiosis, Colonic Inflammation, and Proteome AlterationsSmall, 2020
- Honey Polyphenols Ameliorate DSS‐Induced Ulcerative Colitis via Modulating Gut Microbiota in RatsMolecular Nutrition & Food Research, 2019
- Lactobacillus sakei Alleviates High‐Fat‐Diet‐Induced Obesity and Anxiety in Mice by Inducing AMPK Activation and SIRT1 Expression and Inhibiting Gut Microbiota‐Mediated NF‐κB ActivationMolecular Nutrition & Food Research, 2019
- Epigenetics of T cell agingJournal of Leukocyte Biology, 2018
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015